[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 1562 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
1st Session
S. 1562
To reauthorize the Prematurity Research Expansion and Education for
Mothers who deliver Infants Early Act.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 1, 2025
Mr. Bennet (for himself and Mr. Boozman) introduced the following bill;
which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To reauthorize the Prematurity Research Expansion and Education for
Mothers who deliver Infants Early Act.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``PREEMIE Reauthorization Act of
2025''.
SEC. 2. RESEARCH RELATING TO PRETERM LABOR AND DELIVERY AND THE CARE,
TREATMENT, AND OUTCOMES OF PRETERM AND LOW BIRTHWEIGHT
INFANTS.
(a) In General.--Section 3(e) of the Prematurity Research Expansion
and Education for Mothers who deliver Infants Early Act (42 U.S.C.
247b-4f(e)) is amended by striking ``fiscal years 2019 through 2023''
and inserting ``fiscal years 2025 through 2029''.
(b) Technical Correction.--Effective as if included in the
enactment of the PREEMIE Reauthorization Act of 2018 (Public Law 115-
328), section 2 of such Act is amended, in the matter preceding
paragraph (1), by striking ``Section 2'' and inserting ``Section 3''.
SEC. 3. INTERAGENCY WORKING GROUP.
Section 5(a) of the PREEMIE Reauthorization Act of 2018 (Public Law
115-328) is amended by striking ``The Secretary of Health and Human
Services, in collaboration with other departments, as appropriate, may
establish'' and inserting ``Not later than 18 months after the date of
the enactment of the PREEMIE Reauthorization Act of 2025, the Secretary
of Health and Human Services, in collaboration with other departments,
as appropriate, shall establish''.
SEC. 4. STUDY ON PRETERM BIRTHS.
(a) In General.--The Secretary of Health and Human Services shall
enter into appropriate arrangements with the National Academies of
Sciences, Engineering, and Medicine under which the National Academies
shall--
(1) not later than 30 days after the date of enactment of
this Act, convene a committee of experts in maternal health to
study premature births in the United States; and
(2) upon completion of the study under paragraph (1)--
(A) approve by consensus a report on the results of
such study;
(B) include in such report--
(i) an assessment of each of the topics
listed in subsection (b);
(ii) the analysis required by subsection
(c); and
(iii) the raw data used to develop such
report; and
(C) not later than 24 months after the date of
enactment of this Act, transmit such report to--
(i) the Secretary of Health and Human
Services;
(ii) the Committee on Energy and Commerce
of the House of Representatives; and
(iii) the Committee on Finance and the
Committee on Health, Education, Labor, and
Pensions of the Senate.
(b) Assessment Topics.--The topics listed in this subsection are
each of the following:
(1) The financial costs of premature birth to society,
including--
(A) an analysis of stays in neonatal intensive care
units and the cost of such stays;
(B) long-term costs of stays in such units to
society and the family involved post-discharge; and
(C) health care costs for families post-discharge
from such units (such as medications, therapeutic
services, co-payments for visits, and specialty
equipment).
(2) The factors that impact preterm birth rates.
(3) Opportunities for earlier detection of premature birth
risk factors, including--
(A) opportunities to improve maternal and infant
health; and
(B) opportunities for public health programs to
provide support and resources for parents in-hospital,
in non-hospital settings, and post-discharge.
(c) Analysis.--The analysis required by this subsection is an
analysis of--
(1) targeted research strategies to develop effective
drugs, treatments, or interventions to bring at-risk
pregnancies to term;
(2) State and other programs' best practices with respect
to reducing premature birth rates; and
(3) precision medicine and preventative care approaches
starting early in the life course (including during pregnancy)
with a focus on behavioral and biological influences on
premature birth, child health, and the trajectory of such
approaches into adulthood.
<all>